1. Home
  2. TRT vs ANIX Comparison

TRT vs ANIX Comparison

Compare TRT & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trio-Tech International

TRT

Trio-Tech International

N/A

Current Price

$11.23

Market Cap

109.1M

Sector

Technology

ML Signal

N/A

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

N/A

Current Price

$2.76

Market Cap

114.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRT
ANIX
Founded
1958
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.1M
114.0M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
TRT
ANIX
Price
$11.23
$2.76
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
124.9K
321.5K
Earning Date
05-13-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.82
EPS
0.02
N/A
Revenue
$32,462,000.00
$210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$519.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.42
$2.32
52 Week High
$21.38
$5.46

Technical Indicators

Market Signals
Indicator
TRT
ANIX
Relative Strength Index (RSI) 48.83 29.89
Support Level $9.26 $2.37
Resistance Level $11.81 $3.09
Average True Range (ATR) 0.60 0.19
MACD -0.01 -0.06
Stochastic Oscillator 44.39 9.01

Price Performance

Historical Comparison
TRT
ANIX

About TRT Trio-Tech International

Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operated its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the company operates in the United States (U.S), Singapore, Malaysia, Thailand and China.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: